Saturday, September 28, 2024
HomeTagsStargardt disease

Stargardt disease

Nanoscope Therapeutics Announces First Patient Dosed in STARLIGHT Phase 2 Clinical Trial

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced that the first patient has been dosed in a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics